LAVAL, QUE. — Corealis Pharma has announced completion of a project to expand its plant in Biotech City in Laval, Que.
The $10 million expansion increased the premises of the Quebec-based company from 33,000 to 63,000 square feet, enabling the installation of new laboratories, stated a release.
The firm is active in the Contract Research and Development Organizations (CRO/CDMO) sector with clientele predominantly located in New England and California.
“Corealis elevates the profile of Quebec and the city of Laval, in particular,” stated Laval City coun. Christine Poirier in a statement. “We take immense pride in supporting the directors and employees of this esteemed company, facilitating its continued growth on our soil, thus reaffirming Biotech City as a premier destination for investment and advancement in Quebec’s life sciences landscape.”
Recent Comments